ClinicalTrials.gg
RecruitingNCT06045988Updated Nov 19, 2026

Automated, Assistive, Non-Contact Sleep Quality Monitor for Older Adults

An interventional study of Luna Non-Contact Sleep Quality Monitor System in Sleep Disturbance, Sleep Disorder and Sleep Quality, sponsored by Indiana University. Recruiting at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Indiana University · Not applicable, Interventional, and Diagnostic

How we know

Updated Nov 19, 2026Now RecruitingSite recruiting status changed+8 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 248 studies in Sleep Wake Disorders with a site in United States — 34 open to participants now, 40 under way, 8 of them phase 3. Sleep Wake Disorders · United States.

Planned enrollment
85th of 203
100 · median 70
Started
2026
with 14 others
No phase
123 of 248
17 open now
Primary completion
2027-02
later than 11 of 39 live
Registered
213th of 248
by date

Among the 248 studies in Sleep Wake Disorders with a site in United States, this one is the 85th largest by planned enrollment of the 203 interventional ones that give a count, is one of 15 that started in 2026, is one of 123 with no phase, reaches primary completion later than 11 of the 39 other live ones, and was the 213th registered.

Sleep Wake Disorders

747 studies on the registry are indexed under Sleep Wake Disorders; 181 are open to participants now.

Browse Sleep Wake Disorders studies →

Open to participants now

34 of the 248 studies in Sleep Wake Disorders with a site in United States are open now. Recruiting first, the newest first:

28 more — sign in →

All 34 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 114 Sleep Wake Disorders studies recruiting now, 40 (35%) set no upper age limit and 53 (46%) stop at 75 or younger; 22 take children under 18; 28 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 248 studies in Sleep Wake Disorders with a site in United States, or all of them as a file.
02

Study summary

The goal of this clinical trial is to evaluate the effect of access to Luna device sleep system data on clinician documentation of sleep disorders and sleep treatments and participants' sleep quality. Participants who have sleep quality measured are long-term care (LTC) facility residents. The primary outcome of the trial is the following:

-Documentation of diagnosis or evidence of treatment of sleep disorders in the electronic health record (EHR) in long-term care (LTC) facility residents after 4 weeks of sleep monitoring and 2 weeks of clinical teams' receipt of resident sleep data. We hypothesize that, when real-time System Sleep Data is shared with the clinical team, i.e., LTC staff and healthcare providers in the facility, sleep disturbances will be more readily detected, leading to timelier, better tailored treatment interventions for sleep disturbances, thereby improving sleep quality.

All participating residents will:

  • Have the sleep radar sensor installed for 4 weeks to monitor sleep quality data.
  • Complete pre-intervention and post-intervention surveys that will include measures of sleepiness (Epworth Sleepiness Scale) and attitudes toward technology, technology acceptance, usability and utility.

Additionally, interviews and surveys will be done with LTC staff and healthcare providers in order to seek feedback and reflections on system use and the sleep data clinician user interface.

Read the detailed description

Sleep disturbances often lead to reduced health and lower quality of life and place burden on staff at care facilities. Unfortunately, clinical providers and staff in LTC facilities are limited in their ability to identify and treat these conditions as current methods of sleep quality assessment are either inaccurate, time consuming, or inappropriate for use in routine clinical practice.

The Luna device is a non-contact monitoring system that provides LTC institutions with a practical and enterprise-scale solution to quantify longitudinal sleep quality of residents to inform treatment decisions. Luna gives care providers the information they need to identify sleep disturbances and assess efficacy of interventions.

This trial is a before-after comparison study conducted within LTC facilities in central Indiana. LTC facility resident participants undergo 4 weeks of sleep monitoring by the Luna device. Documentation and sleep metrics of residents by the clinical team during the first 2 weeks participants undergo monitoring (and the clinical team has no Luna data access) to the second 2 weeks participants undergo sleep monitoring (with data access).

The primary outcome is documentation of diagnosis or evidence of treatment of sleep disorders in participating LTC residents' medical records after 4 weeks of sleep monitoring if data from the Luna device shows evidence of sleep disorders or disturbance.

We hypothesize that, when real-time System Sleep Data is shared with the clinical team, i.e., LTC staff and healthcare providers in the facility, sleep disturbances will be more readily detected, leading to timelier, better tailored treatment interventions for sleep disturbances, thereby improving sleep quality.

We also want to learn about the clinical team's experience interacting with the Luna device's data and interface and so will interview them about their experience after residents they take care of have undergone 4 weeks of sleep monitoring.

Each LTC resident participant will undergo a baseline and final (4-week) assessment that will include measures of sleepiness (Epworth Sleepiness Scale) and attitudes toward technology, technology acceptance, usability and utility. Additionally, one-time qualitative interviews and surveys will be done with LTC staff and healthcare providers in order to seek feedback and reflections on system use and the sleep data user interface.

03

Conditions studied

  • Sleep Disturbance
  • Sleep Disorder
  • Sleep Quality

Keywords

  • Sleep Assessment
  • Sleep Disorder
  • Technology
  • Long-Term Care
  • Sleep Monitoring
04

Who can participate

The criteria were revised on the registry on Nov 19, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

For the main outcomes:

-Resident of long-term care (LTC) facility study site location for a minimum of 30 days.

For the interviews and surveys conducted with LTC staff and healthcare providers:

  • Provided direct care to one or more participating residents during the resident(s)' participation in the main outcomes of the study and had access to sleep monitoring data for the resident during the study period
  • Clinical staff identified by LTC leadership

Exclusion criteria

Exclusion Criteria

For the main outcomes:

-Currently on hospice

For the interviews and surveys conducted with LTC staff and healthcare providers:

-Did not provide direct care to one or more participating residents during the resident(s)' participation in the main outcomes of the study

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Long-Term Care Facility Residents

    Participating residents undergo 4 weeks of sleep monitoring by the Luna device.

    Device: Luna Non-Contact Sleep Quality Monitor System

Interventions

  • DeviceLuna Non-Contact Sleep Quality Monitor System

    Residents of long-term care facilities will utilize a sleep monitoring device for the four-week period they are involved in the study.

06

What researchers measure

Primary outcomes

  1. Documentation of diagnosis or treatment of sleep disorders

    Documentation of diagnosis or evidence of treatment of sleep disorders in the electronic health record (EHR) in long-term care (LTC) facility residents after 4 weeks of sleep monitoring and 2 weeks of clinical teams' receipt of resident sleep data

    Time frame: 4-weeks

Secondary outcomes

  1. Change in Total Nocturnal Sleep Time (TNST) as measured by the Luna device in participating LTC facility residents after 4 weeks of sleep monitoring.

    Change in total duration of sleep that occurs during nighttime hours, as measured in minutes by the Luna device in participating LTC facility residents, after 4 weeks of sleep monitoring.

    Time frame: 4-weeks

  2. Change in Sleep Efficiency (SE) as measured by the Luna device in participating LTC facility residents after 4 weeks of sleep monitoring.

    Change in the percentage of time participants spend sleeping while in bed, as measured by the Luna device in participating LTC facility residents, after 4 weeks of sleep monitoring.

    Time frame: 4-weeks

  3. Change in Sleep Onset Latency (SOL) as measured by the Luna device in participating LTC facility residents after 4 weeks of sleep monitoring.

    Change in duration of time for participants to transition from wakefulness to sleep, as measured in minutes by the Luna device in participating LTC facility residents, after 4 weeks of sleep monitoring.

    Time frame: 4-weeks

  4. Change in Wake After Sleep Onset (WASO) count/duration as measured by the Luna device in participating LTC facility residents after 4 weeks of sleep monitoring.

    Change in amount of wakefulness occurring after sleep onset, as measured in quantity and minutes by the Luna device in participating LTC facility residents, after 4 weeks of sleep monitoring.

    Time frame: 4-weeks

  5. Change in Epworth Sleepiness Scale total score in LTC facility residents after 4 weeks of sleep monitoring

    The Epworth Sleepiness Scale is a validated, self-report measure of sleepiness. It is an 8-item questionnaire that measures one's tendency to become sleepy using a scale from 0 (no chance of dozing) to 3 (high chance of dozing). The total score is based on a scale of 0 to 24, with a score of 24 indicating the potential need for medical attention.

    Time frame: 4-weeks

  6. LTC facility residents' experience participating in the study after 4 weeks of sleep monitoring

    A series of qualitative questions about attitudes toward technology, technology acceptance, usability, and utility

    Time frame: 4-weeks

  7. Feedback and reflections from participating LTC facilities' clinical teams on the Luna sleep system's use and its user data interface

    Qualitative feedback and reflections from participating LTC facilities' clinical teams on the Luna sleep system's use and its user data interface after residents they take care of have participated in 4 weeks of sleep monitoring and clinicians have received 2 weeks of resident sleep data

    Time frame: 4-weeks

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Oct 2026 (actual). Primary completion is estimated for Feb 2027, 4 months after the start.

Of 214 non-industry interventional studies with no phase under Sleep Wake Disorders, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 40. This study's planned 4 months is below that.

Counting every sponsor, half of 249 studies reached it within 19 months; a quarter within 6 and three quarters within 37.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 19, 2026: start Jul 2026 → Oct 2026, primary completion Dec 2026 → Feb 2027 and completion Dec 2026 → Feb 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 7, 2023
First posted
Sep 21, 2023
StartActual
Oct 27, 2026was Jul 2026
Primary completionEst.
Feb 2027was Dec 2026
CompletionEst.
Feb 2027was Dec 2026
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Nov 19, 2026
Sites
Indiana University School of Medicine is now Recruiting
Nov 19, 2026
Start date
Jul 2026→Oct 27, 2026 (actual)
Nov 19, 2026
Primary completion
Dec 2026→Feb 2027
Nov 19, 2026
Study completion
Dec 2026→Feb 2027
Nov 19, 2026
Eligibility
Criteria largely rewritten (11 changes)
What changed in the criteria
Inclusion criteria
  • RemovedDiagnosis of Alzheimer's Disease (AD) or Alzheimer's Disease Related Dementias (ADRD)
  • AddedFor the main outcomes:
  • EditedResidents-Resident of long-term care (LTC) facility study site location for a minimum of 30 days.
  • RemovedWillingness to consent to study or when a potential participant lacks decision making capacity (determined by LTC facility clinical provider) willingness of a Legally Authorized Representative (LAR) to consent to study participation on potential participant's behalf.
  • AddedFor the interviews and surveys conducted with LTC staff and healthcare providers:
  • AddedProvided direct care to one or more participating residents during the resident(s)' participation in the main outcomes of the study and had access to sleep monitoring data for the resident during the study period
  • AddedClinical staff identified by LTC leadership
Exclusion criteria
  • AddedFor the main outcomes:
  • Edited-Currently on hospice
  • AddedFor the interviews and surveys conducted with LTC staff and healthcare providers:
  • Added-Did not provide direct care to one or more participating residents during the resident(s)' participation in the main outcomes of the study
Nov 19, 2026
Interventions
Changed Non-Contact Sleep Quality Monitor System→Luna Non-Contact Sleep Quality Monitor System. Arm changed Long-Term Care Facility Residents with Alzheimer's Disease or other Related Dementias→Long-Term Care Facility Residents
Nov 19, 2026
Primary outcomes
1 edited
What changed in the outcomes
  • EditedDocumentation of diagnosis or treatment of sleep disorders or treatmentTime frame: 4-weeks
Nov 19, 2026
Secondary outcomes
1 edited, 6 added, 8 removed
What changed in the outcomes
  • EditedChange in Epworth Sleepiness Scale Total Score Over Timetotal score in LTC facility residents after 4 weeks of sleep monitoringTime frame: 4-weeks
  • AddedChange in Total Nocturnal Sleep Time (TNST) as measured by the Luna device in participating LTC facility residents after 4 weeks of sleep monitoring.Time frame: 4-weeks
  • AddedChange in Sleep Efficiency (SE) as measured by the Luna device in participating LTC facility residents after 4 weeks of sleep monitoring.Time frame: 4-weeks
  • AddedChange in Sleep Onset Latency (SOL) as measured by the Luna device in participating LTC facility residents after 4 weeks of sleep monitoring.Time frame: 4-weeks
  • AddedChange in Wake After Sleep Onset (WASO) count/duration as measured by the Luna device in participating LTC facility residents after 4 weeks of sleep monitoring.Time frame: 4-weeks
  • AddedLTC facility residents' experience participating in the study after 4 weeks of sleep monitoringTime frame: 4-weeks
  • AddedFeedback and reflections from participating LTC facilities' clinical teams on the Luna sleep system's use and its user data interfaceTime frame: 4-weeks
  • RemovedChange in Sleep Quality Over Time: Total Nocturnal Sleep Time (TNST)Time frame: 4-weeks
  • RemovedChange in QOL-AD Over TimeTime frame: 4-weeks
  • RemovedAttitudes Toward TechnologyTime frame: 4-weeks
  • RemovedTechnology Acceptance Survey QuestionnaireTime frame: 4-weeks
  • RemovedSystem UsageTime frame: 4-weeks
  • RemovedChange in Sleep Quality Over Time: Sleep Efficiency (SE)Time frame: 4-weeks
  • RemovedChange in Sleep Quality Over Time: Sleep Onset Latency (SOL)Time frame: 4-weeks
  • RemovedChange in Sleep Quality Over Time: Wake After Sleep Onset (WASO)Time frame: 4-weeks
Nov 19, 2026
Title
Automated, Assistive, Non-Contact Sleep Quality Monitor for Individuals With Alzheimer's DiseaseOlder Adults
Nov 19, 2026
Sponsor
Collaborators removed: University of Minnesota·Mayo Clinic
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Not yet recruiting→Recruiting
    Indiana University School of Medicine is now Recruiting
    Start date Jul 2026→Oct 27, 2026 (now actual)
    Primary completion Dec 2026→Feb 2027
    Study completion Dec 2026→Feb 2027
    Eligibility Criteria largely rewritten (11 changes)
    What changed in the criteria
    Inclusion criteria
    • RemovedDiagnosis of Alzheimer's Disease (AD) or Alzheimer's Disease Related Dementias (ADRD)
    • AddedFor the main outcomes:
    • EditedResidents-Resident of long-term care (LTC) facility study site location for a minimum of 30 days.
    • RemovedWillingness to consent to study or when a potential participant lacks decision making capacity (determined by LTC facility clinical provider) willingness of a Legally Authorized Representative (LAR) to consent to study participation on potential participant's behalf.
    • AddedFor the interviews and surveys conducted with LTC staff and healthcare providers:
    • AddedProvided direct care to one or more participating residents during the resident(s)' participation in the main outcomes of the study and had access to sleep monitoring data for the resident during the study period
    • AddedClinical staff identified by LTC leadership
    Exclusion criteria
    • AddedFor the main outcomes:
    • Edited-Currently on hospice
    • AddedFor the interviews and surveys conducted with LTC staff and healthcare providers:
    • Added-Did not provide direct care to one or more participating residents during the resident(s)' participation in the main outcomes of the study
    Primary outcomes 1 edited
    What changed in the outcomes
    • EditedDocumentation of diagnosis or treatment of sleep disorders or treatmentTime frame: 4-weeks
    Secondary outcomes 1 edited, 6 added, 8 removed
    What changed in the outcomes
    • EditedChange in Epworth Sleepiness Scale Total Score Over Timetotal score in LTC facility residents after 4 weeks of sleep monitoringTime frame: 4-weeks
    • AddedChange in Total Nocturnal Sleep Time (TNST) as measured by the Luna device in participating LTC facility residents after 4 weeks of sleep monitoring.Time frame: 4-weeks
    • AddedChange in Sleep Efficiency (SE) as measured by the Luna device in participating LTC facility residents after 4 weeks of sleep monitoring.Time frame: 4-weeks
    • AddedChange in Sleep Onset Latency (SOL) as measured by the Luna device in participating LTC facility residents after 4 weeks of sleep monitoring.Time frame: 4-weeks
    • AddedChange in Wake After Sleep Onset (WASO) count/duration as measured by the Luna device in participating LTC facility residents after 4 weeks of sleep monitoring.Time frame: 4-weeks
    • AddedLTC facility residents' experience participating in the study after 4 weeks of sleep monitoringTime frame: 4-weeks
    • AddedFeedback and reflections from participating LTC facilities' clinical teams on the Luna sleep system's use and its user data interfaceTime frame: 4-weeks
    • RemovedChange in Sleep Quality Over Time: Total Nocturnal Sleep Time (TNST)Time frame: 4-weeks
    • RemovedChange in QOL-AD Over TimeTime frame: 4-weeks
    • RemovedAttitudes Toward TechnologyTime frame: 4-weeks
    • RemovedTechnology Acceptance Survey QuestionnaireTime frame: 4-weeks
    • RemovedSystem UsageTime frame: 4-weeks
    • RemovedChange in Sleep Quality Over Time: Sleep Efficiency (SE)Time frame: 4-weeks
    • RemovedChange in Sleep Quality Over Time: Sleep Onset Latency (SOL)Time frame: 4-weeks
    • RemovedChange in Sleep Quality Over Time: Wake After Sleep Onset (WASO)Time frame: 4-weeks
    Interventions Changed Non-Contact Sleep Quality Monitor System→Luna Non-Contact Sleep Quality Monitor System. Arm changed Long-Term Care Facility Residents with Alzheimer's Disease or other Related Dementias→Long-Term Care Facility Residents
    Sponsor Collaborators removed: University of Minnesota·Mayo Clinic
    Title Automated, Assistive, Non-Contact Sleep Quality Monitor for Individuals With Alzheimer's DiseaseOlder Adults
    + 4 other changes: index terms, verification date, description and conditions

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06045988
Lead sponsor
Indiana University
Collaborators
Innovative Design Labs, National Institute on Aging (NIA), Regenstrief Institute, Inc.
Responsible party
Kathleen T. Unroe (Professor of Medicine, Geriatrics, Indiana University) — Principal investigator
First posted
Sep 21, 2023
Start date
Oct 27, 2026
Primary completion
Feb 2027 (estimated)
Completion
Feb 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Kathleen Unroe, MD, MHA, MS
Contact
kunroe@iu.edu
317-274-9227
Richard Holden, PhD, MS
Contact
rjholden@iu.edu
317-278-5323
Kathleen Unroe, MD, MHA, MS
principal investigator · Indiana University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion